Connection

SHARON PLON to Pharmacogenomic Variants

This is a "connection" page, showing publications SHARON PLON has written about Pharmacogenomic Variants.
Connection Strength

0.213
  1. Should secondary pharmacogenomic variants be actively screened and reported when diagnostic genome-wide sequencing is performed in a child? Genet Med. 2024 02; 26(2):101033.
    View in: PubMed
    Score: 0.213
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.